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Edited by Hans-Dieter KlenkAbstract The structural determinants underlying the function-
ality of viral internal fusion peptides (IFPs) are not well
understood. We have compared EBOwt (GAAIGLAWIPY-
FGPAAE), representing the IFP of the Ebola fusion protein
GP, and EBOmut (GAAIGLAWIPYFGRAAE) derived from a
non-functional mutant with conserved Pro537 substituted by
Arg. P537R substitution did not abrogate peptide-membrane
association, but interfered with the ability to induce bilayer
destabilization. Structural determinations suggest that Pro537 is
required to preserve a membrane-perturbing local conformation
in apolar environments.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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It is currently postulated that viral proteins mediating virus-
cell fusion processes insert into target cell membranes through
specialized hydrophobic sequences termed ‘‘fusion peptides’’
(FPs) [1–3]. These conserved domains are absolutely required
for the fusogenic activity, but the structural and functional
determinants that constrain their amino acid compositions
remain unknown. While several FPs are free N-terminal se-
quences of the polypeptide chain that protrude from the sur-
face of the virion, others constitute internal sequences [2,4]. An
important body of experimental information is available on
the way N-terminal fusion peptides (NFPs) become integral in
membranes, as well as on the type of perturbations they may
induce therein [for reviews see [5–7]]. Comparatively less is
known on the type of interactions established by internal fu-
sion peptides (IFPs) with membranes.* Corresponding author. Fax: +34-94-6013360.
E-mail address: gbpniesj@lg.ehu.es (J.L. Nieva).
Abbreviations: ANTS, 8-aminonaphthalene-1,3,6-trisulfonic acid so-
dium salt; CD, circular dichroism; DPX, p-xylenebis(pyridinium)bro-
mide; EBOwt, synthetic GAAIGLAWIPYFGPAAE amino acid
sequence; EBOmut, synthetic GAAIGLAWIPYFGRAAE amino acid
sequence; IFP, internal fusion peptide; LUV, large unilamellar vesicles;
NATA, N-acetyl-L-tryptophanamide; NFP, N-terminal fusion pep-
tide; POPC, 1-palmitoyl-2-oleoylphosphatidylcholine; PI, phosphati-
dylinositol; RET, resonance energy transfer; TFE, triﬂuoroethanol
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doi:10.1016/j.febslet.2004.06.006Predictive structural analyses indicate that IFPs are seg-
mented into two regions intervened by a putative turn or a
loop, which usually contains one or more Pro residues [8]. This
organization seems to be fundamental to sustain the fusogenic
function [8]. Gallaher [4] predicted the existence of an IFP in
GP2, the fusogenic subunit of Ebola surface protein GP [9,10].
Biophysical characterization by our group conﬁrmed the
ability of the predicted Ebola IFP sequence to associate with
phosphatidylinositol (PI)-containing lipid vesicles and perturb
their integrity [11,12]. Mutational analysis by Ito et al. [13]
further supported a fusion peptide role for this GP2 sequence.
These authors showed that non-conservative substitutions of
Pro residues in positions 533 and 537 impair GP functionality.
In particular, P533R substitution renders an Ebola GP2 pro-
tein deﬁcient in maturation, while P537R abolishes GP2 ac-
tivity without aﬀecting transport to cell surface or
incorporation into virions. This suggests that the conserved
Pro537 is directly involved in the Ebola-cell fusion process
mediated by GP2.
In order to establish the speciﬁcity of Ebola IFP-induced
membrane destabilization and the involvement of the
conserved Pro537 in the process, we compare here EBOwt
(GAAIGLAWIPYFGPAAE) and EBOmut (GAAIGLAW-
IPYFGRAAE), two synthetic sequences that represent IFP
domains (residues 524–540) in fusion-active and fusion-inac-
tive GP2 proteins, respectively. Our data support the notion
that Pro and Arg residues at position 537 promote the adop-
tion of diﬀerent structures in the low-polarity membrane en-
vironment. The P537R substitution confers to the sequence an
aﬃnity for electrically neutral phosphatidylcholine (PC)
membranes, but abrogates the ability to destabilize large un-
ilamellar vesicles (LUV) composed of anionic PI. Tyr-to-Trp
energy transfer and circular dichroism suggest that Pro537
might be implied in stabilizing a turn-like structure, which
would be maintained in the membrane apolar milieu. We
conclude that IFP insertion into the target membrane is not
enough to sustain Ebola GP activity, and propose that adop-
tion of an interfacial Pro-based structure is crucial for the
promotion of membrane destabilization during Ebola virus-
cell fusion.2. Materials and methods
1-Palmitoyl-2-oleoylphosphatidylcholine (POPC), liver PI, N-(7-ni-
tro-benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (N-NBD-PE)
and N-(lissamine Rhodamine B sulfonyl)phosphatidylethanolamineblished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Turn propensity within Ebola IFP. Normalized turn po-
tentials described by Monne et al. [31] for model transmembrane se-
quences were used to calculate average values within sliding windows
of ﬁve amino acids. (B) Multiple sequence alignment of ﬁlovirus IFP
domains by CLUSTALW. Invariant Pro residues are indicated in
bold. Pro537 is denoted by ‘‘*’’, and Trp531 and Tyr534 (positions in
Zaire strain) are denoted by arrows.
262 M.J. Gomara et al. / FEBS Letters 569 (2004) 261–266(N-Rho-PE) were purchased from Avanti Polar Lipids (Birmingham,
AL, USA). 8-Aminonaphthalene-1,3,6-trisulfonic acid sodium salt
(ANTS) and p-xylenebis(pyridinium)bromide (DPX) were from Mo-
lecular Probes (Junction City, OR, USA). D2O, triﬂuoroethanol
(TFE), N-acetyl-L-tryptophanamide (NATA) and Triton X-100 were
obtained from Sigma (St. Louis, MO, USA). All other reagents were of
analytical grade. The GAAIGLAWIPYFGPAAE (EBOwt) and GA-
AIGLAWIPYFGRAAE (EBOmut) peptides were synthesized by solid-
phase synthesis using Fmoc chemistry as C-terminal carboxamides and
puriﬁed (estimated homogeneity >90%) by HPLC. Peptide stock so-
lutions were prepared in dimethyl sulfoxide (spectroscopy grade). The
YW, PY and AW dipeptides used for calibrating energy transfer
experiments were obtained from Bachem (Bubendorf, Switzerland).
LUV were prepared following the extrusion method of Hope et al.
[14] in 5 mM HEPES and 100 mM NaCl (pH 7.4) buﬀer. Release of
vesicular contents to the medium and mixing of lipids were monitored
by the ANTS/DPX and resonance energy transfer (RET) assays, re-
spectively, as described in [15]. Trp-ﬂuorescence emission of peptides in
the presence of LUV was recorded in a Perkin–Elmer MPF-66 spec-
troﬂuorimeter with excitation set at 280 nm. The signal was further
corrected for dilution and inner ﬁlter eﬀects using the soluble Trp
analog NATA following the procedure described in [16]. Tyr to Trp
energy transfer in EBOwt and EBOmut was measured according to the
methods described in [17,18]. Peptide excitation spectra (emission set at
345 nm, at which only Trp emits) were compared with spectra obtained
for transfer eﬃciencies ðeÞ of 1 and 0. The e ¼ 1 and e ¼ 0 references
were experimentally obtained using YW (1 lM), and an equimolar
mixture of PY and AW (1 lM each), respectively. Subtraction from
YW excitation spectrum (normalized to the intensity value at k ¼ 295
nm) yields the ‘‘excitation diﬀerence spectrum’’ for each peptide. Ef-
ﬁciency of transfer from Tyr to Trp (etyr) was calculated by adjusting
the excitation diﬀerence spectrum to:
QðkÞ ¼ ftrpðkÞ þ etyrftyrðkÞ ð1Þ
where QðkÞ is the relative quantum yield of Trps excited at wavelength
k, and ftrp and ftyr are the fractions of light absorbed by Tyr and Trp as
obtained from absorption spectra using PY-AW mixtures.
Circular dichroism (CD) measurements were carried out on a ther-
mally controlled Jasco 810 CD spectropolarimeter (Eaton, USA)
calibrated routinely with (1S)-(+)-10-camphorsulfonic acid and am-
monium salt. The spectra were measured in a 1 mm path-length quartz
cell. Data were taken with a 0.1 nm step size, 50 nm/min speed, and the
results of 10 scans were averaged. CD spectra were taken at 25 C in 5
mM HEPES, 100 mM NaCl (pH 7.4). Peptide concentration was 30
lM as determined by UV spectroscopy using e ¼ 1450 M1cm1 for
tyrosine and e ¼ 5570 M1cm1 for tryptophan [19]. To simplify the
comparison between diﬀerent TFE percentages and to verify the av-
erage secondary structure content, ellipticity spectra were converted
from millidegrees to secondary structure fractions using model-protein
CD spectra [20], according to the software speciﬁcations (Jasco Sec-
ondary Structure Estimation Version 1.00).3. Results and discussion
According to the current model of viral fusion, FPs bear an
intrinsic capacity to disrupt the target bilayer architecture after
insertion and directly mediate membrane merging [1–7]. Se-Table 1
Energetics of FP-membrane partitioning in processed type I viral fusion pro
FP type DG
Ebola GPb: (524–539) IFP )3.
HIV-1 env: (512–527) NFP )3.
Inﬂuenza HAc: (340–355) NFP )0.
Sendai F: (117–132) NFP )2.
RSV env: (427–442) IFP )0.
Free energies (DG) are given in kcalmol1.
a wiu, transfer from water to interface, unfolded; wif, transfer from water to
bComputed for 16 residues, comprising N-termini of NFPs, and homologou
U31033 (Ebola GP); M15654 (HIV-1 env); M31689 (Inﬂuenza HA); M1239
cComputed for unprotonated/protonated Asp and Glu residues.quence features listed below suggest that Ebola IFP might
adopt a bent structure at membrane interfaces. First, plot in
Fig. 1A shows the tendency to adopt interfacial turns within
Ebola IFP sequence. Speciﬁcally, the dominance of turn-in-
ducing residues (normalized turn potential >1) over non-in-
ducing ones (turn potential <1) is clearly noticeable in the
inter-Pro region, in which virtually all residues are turn in-
ducers. This suggests that within Gly- and Ala-rich Ebola IFP
sequence, Pro residues might structurally constrain the inher-
ently ﬂexible sequence into a bent conformation. Sequence
alignment (Fig. 1B) further reveals that the inter-Pro region is
absolutely conserved among Ebola strains, while in Marburg
this region displays a conservative PheTyr substitution.
Second, Ebola IFP would minimize its interacting energy by
remaining associated with the membrane interface region
(Table 1). The calculated free energies of transfer from water
to membrane interfaces computed for the unfolded (DGwiu)
and folded (DGwif ) Ebola IFP sequences are clearly larger
than DGwo, which corresponds to the free energy of insertingteins
wiu
a DGwif a DGwoa
3 )11.3 )1.8
4 )11.4 )1.0
4/)4.5 )7.6/)12.5 5.9/)1.2
3 )10.3 )1.9
6 )8.6 )1.4
interface, folded; wo, transfer from water to octanol [21,22].
s most hydrophobic stretches of IFPs. Gene Bank accession numbers:
6 (Sendai F); V01197 (RSV env).
Fig. 2. Interaction of EBOwt and EBOmut with lipid vesicles.
(A) Peptide-induced LUV permeabilization (ANTS/DPX eﬄux) as a
function of time (peptides added at the time indicated by the arrow); a:
EBOwt and PI LUV, b: EBOwt and POPC LUV, c: EBOmut and PI
LUV, and d: EBOmut and POPC LUV. In all cases, lipid concentration
was 50 lM and the added peptide-to-lipid mole ratio, 0.2. (B) Per-
meabilization of PI (circles) and POPC (squares) vesicles induced by
EBOwt (ﬁlled symbols) and EBOmut (empty symbols) as a function of
the added peptide-to-lipid mole ratio. Final extents were measured
10 minutes after peptide addition. Conditions otherwise as in (A).
(C) Fluorescence emission spectra of EBOwt and EBOmut incubated
with increasing amounts of POPC or PI LUV. Lipid concentrations
were (spectra from right to left): 0 (absence of lipid, thick line), 25, 75,
100, 250, 500 and 750 lM. Peptide concentration was 1 lM. Thick
dashed lines in bottom panels correspond to the emission spectra in the
presence of TFE (25% v/v).
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[21,22]. Thus, energy values in Table 1 are consistent with a
preference of Ebola IFP for remaining associated to the
membrane interface region (rather than for adopting trans-
membrane conﬁgurations) when the sequence is transferred
from water into membranes, as proposed to occur during the
fusion reaction cycle [1–7]. In general, values listed in Table 1
show similar trends among NFPs and IFPs derived from class
I fusion proteins that activate upon cleavage [2].
The previous analyses suggest a functional role for the Ebola
IFP inter-Pro region. Therefore, we explored in experimental
model systems the eﬀects of P537R substitution, described to
abolish Ebola GP function. Direct implication of FPs in virus-
cell fusion is supported by studies using model membranes,
membrane mimetic systems and synthetic peptide fragments
representing functional and non-functional FP sequences,
which demonstrate that, after insertion, only functional se-
quences generate target-membrane perturbations (reviewed in
[7]). The initial perturbations seem to originate at their ca-
pacity to form pores, an eﬀect that may result in the permea-
bilization of dispersed vesicles. Thus, induction of vesicle
permeability has been shown to correlate well with FP func-
tionality in most instances. In principle, P537R substitution
might aﬀect IFP capacity to insert into membranes, or interfere
with the adoption of a functional destabilizing structure. Fig. 2
illustrates the eﬀect of this mutation on the ability of the
peptide to associate with and destabilize phospholipid vesicles.
Addition of EBOwt to PI LUV at high peptide-to-lipid mole
ratios induced vesicle destabilization and leaking out of
aqueous contents (panels A and B). In accordance with pre-
viously reported results showing the incapacity of this peptide
to associate with PC-based vesicles [11], the wt peptide did not
destabilize POPC LUV. The P537R-representing EBOmut was
unable to induce contents eﬄux from PI or POPC vesicles even
at the highest peptide-to-lipid mole ratio tested. However,
changes in ﬂuorescence emission of the single Trp in the
presence of LUV conﬁrmed that EBOmut was indeed able to
interact with PI, as well as with POPC vesicles (panel C). The
emission in buﬀer of EBOmut, 355 nm, shifted to lower wave-
lengths upon addition of LUV or in the presence of mem-
brane-mimic TFE (25% v/v), while the ﬂuorescence intensity
increased. These changes reﬂect that the tryptophan residue,
fully exposed to water in buﬀer, moves to an environment of
lower polarity provided by the vesicles or the organic solvent
[18]. In comparison EBOwt-Trp emission was centered at 347
nm in buﬀer and did not signiﬁcantly change in presence of
LUV or after TFE (25% v/v) addition. This observation sug-
gests that EBOwt-Trp in membranes is partially shielded from
water but remains in contact with hydrogen-bonding groups
[18], which is consistent with immersion of the ﬂuorophore
into the membrane-water interface environment.
In summary, P537R-representing IFP sequence is deﬁcient
at inducing membrane perturbations upon membrane inser-
tion, a fact that correlates well with the blocking eﬀect exerted
by this mutation on Ebola GP activity. Moreover, P537R-like
substitution enables insertion into POPC bilayers. A possible
explanation for this eﬀect might be that, in contrast to the
parental sequence, the Arg-containing variant undergoes par-
titioning-coupled folding in this model system. In support of
this notion, it should be mentioned that Arg side chain is
largely hydrophobic, with the charged moiety at the tip, and,
therefore, able to reach up into the water-membrane interface,even from positions located quite deep into the hydrophobic
core of the bilayer [23]. We postulate that PI bilayer sustains
interactions of wild-type Ebola IFP because its interface, rich
264 M.J. Gomara et al. / FEBS Letters 569 (2004) 261–266in H-bonding moieties, provides the suitable environment for
inserting a partially folded inter-Pro bent rigid structure. Thus,
our hypothesis states that inter-Pro region would not undergo
major conformational changes in low-polarity environments,
whereas, in the absence of the conformational con-
straints imposed by Pro537, it would transit to a diﬀerent local
structure.
To test the former hypothesis, we ﬁrst measured the energy
transfer between donor Tyr534, located within the inter-Pro
region (Fig. 1), and acceptor Trp531, in environments of dif-
ferent polarity. Tyr-to-Trp energy transfer eﬃciency (‘‘e’’,
dotted lines in Fig. 3) was calibrated in the diﬀerent media
considering the relative absorbance of the aromatic residues in
mixtures of Ala-Trp and Pro-Tyr dipeptides [17,18]. The Tyr-
to-Trp ‘‘e’’ values within EBOwt and EBOmut sequences were
experimentally obtained by measuring the Trp-emission (set at
345 nm) for various excitation wavelengths. Under the same
experimental conditions, Trp–Tyr dipeptide emission was
considered to correspond to e ¼ 1. The trp excitation diﬀer-
ence spectra (solid and dashed lines in Fig. 3) were computed
relative to Trp-Tyr excitation spectrum, which was normalized
to the value obtained at excitation of 295 nm, where only Trp
absorbs. Trp excitation diﬀerence spectra are shown for the
peptides in buﬀer (panel A) and in the presence of TFE (25% v/
v) (panel B). Comparable eﬃciencies (e  0:2) were measured
in buﬀer for both peptides. After peptide structuring in the
presence of TFE, transfer eﬃciency in EBOmut signiﬁcantlyFig. 3. Wavelength dependence of the relative quantum yield of Trp in
buﬀer (panel A) and in the presence of TFE (25% v/v) (panel B). The
dotted curves correspond to spectra based on the fractional absor-
bances. Energy transfer eﬃciency values ðeÞ were calculated according
to Eq. (1). Relative quantum yields of Trp531 are denoted by solid
(EBOwt) and dashed spectra (EBOmut).
Fig. 4. Structural CD determination. (A) Far UV CD spectra in buﬀer
(circles) and in the presence of TFE (25% v/v) (inverted triangles) of
EBOwt (ﬁlled symbols) and EBOmut (empty symbols). Spectra values
are expressed as mean molar ellipticity per residue. Peptide concen-
tration was 30 lM. (B) Structure content of EBOwt (ﬁlled symbols and
solid line) and EBOmut (empty symbols and dashed line) as a function
of the TFE concentration. Conditions otherwise as in panel (A).increased (e  0:5) while that measured in EBOwt remained
roughly the same (e  0:3). These data indicate that the in-
tramolecular Tyr-to-Trp distance in EBOwt is not appreciably
aﬀected by low-polarity, while it changes by becoming shorter
in EBOmut.
CD spectra measured in environments of decreasing polarity
also conﬁrmed the existence of conformational diﬀerences
between EBOwt and EBOmut peptides (Fig. 4). Spectra in buﬀer
(Fig. 4A) indicated mainly random conformations for both
peptides. However, ellipticities measured at 220 nm were
Fig. 5. Calcium-assisted fusion (membrane lipid mixing, RET assay) of
PI LUV. Mixing of lipids as a function of time after addition (indicated
by the arrow) of EBOwt (a) or EBOmut (b). The peptides were added at
the peptide-to-lipid mole ratio of 0.2 and ﬁnal calcium concentration
was 5 mM. Lipid concentration was 100 lM.
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than EBOmut in low-polarity solvents. In the case of EBOwt,
increasing amounts of TFE induced stabilization of a-helical
structures, which seemed to be produced at the expense of the
initial b-type structure content, while the turn content re-
mained roughly constant at all studied TFE concentrations
(Fig. 4B). In contrast, TFE contributed to stabilize a-helical
and b-type structures in EBOmut, while turns were virtually
eliminated in the low-polarity medium. Thus, CD determina-
tions would be consistent with the presence in Ebola IFP of
turn-like structures in aqueous buﬀer that are preserved in low-
polarity environments. The fact that P537R substitution
caused the loss of such component in the low-polar medium
supports the involvement of Pro537 in sustaining this type of
conformations.
Finally we tested the eﬀect of P537R substitution in the
context of fusion assisted by calcium [7,12]. So far, our results
indicate that the sequence derived from the wild-type Ebola
IFP is capable to induce perturbations in dispersed vesicles.
This process mimics initial interactions of GP ectodomain with
target bilayer. Formation of helical bundles after GP activa-
tion is postulated to bring into close contact the membranes to
be fused [24,25]. Subsequent membrane merger evolves within
apposed bilayers through a deﬁned pathway of lipidic inter-
mediates [2,5,7]. In order to test the activity of FP sequences in
aggregated bilayers, in previous works we have used cations to
modulate the aggregational state of membranes [12,15]. Par-
ticularly, EBOwt has been shown to induce fusion (membrane
lipid-mixing) of PI LUV in the presence of 5 mM Ca2þ [12].
Results displayed in Fig. 5 demonstrate that EBOmut was de-
ﬁcient at inducing lipid-mixing under similar experimental
conditions.4. Concluding remarks
Ebola GP2 belongs to class I of viral fusion proteins [26].
The model for GP2-mediated fusion postulates that formation
by the ectodomain of a low-energy helical bundle facilitatesclose apposition of viral and cell membranes, which would be
anchored through transmembrane and IFP domains, respec-
tively [24,25]. Within this framework, the results in this work
support an active role for viral IFPs in membrane destabili-
zation during the fusion process. A single P537R substitution
abolishes the capacity of the Ebola IFP sequence to induce
aqueous content leakage from vesicles, but not its ability to
associate with lipid bilayers. In addition, adoption of the initial
perturbing structure might condition the ability of the se-
quence to catalyze subsequent steps along the fusion pathway.
This argues against a passive role of the sequence as a fea-
tureless hydrophobic membrane anchor that inserts into the
target cell membrane.
The fact that becoming integral to membranes does not by
itself sustain FP functionality has also been conﬁrmed for
substitutions at the N-terminal region of HIV and inﬂuenza
NFPs [7]. Similarly to the mutation described here, these
substitutions do not impair NFP-membrane association but
abolish NFP ability to destabilize lipid vesicles after insertion.
The atomic structure of inﬂuenza fusion domain resolved in a
micellar environment at pH 5.0 reveals the putative functional
organization of NFPs [27]. The a-helical amino terminus is
followed by a bent sequence that confers an inverted ‘V’ ap-
pearance to the structure. Recent structural studies indicate
that G1V substitution, known to block hemagglutinin-induced
fusion, might also alter the membrane-perturbing ‘‘inverted V’’
conformation adopted by inﬂuenza NFP in lipidic environ-
ments [28]. G1V mutation locks inﬂuenza NFP into a linear
helical structure, which would be oriented approximately
parallel to the membrane surface.
Our data support a role for Pro537 in sustaining a mem-
brane-perturbing structure of Ebola IFP. Pro residues have
been described to play important structural roles in mem-
brane-inserted peptide chains, speciﬁcally promoting kinks at
the level of the membrane interface (see [29] and references
therein). In fact, it has been shown that Pro residues display
the highest turn induction propensity at the membrane inter-
face in poly(Leu) stretches [30,31]. We hypothesize that the
presence of a bent located at the inter-Pro region of the Ebola
IFP is directly related to its capacity to perturb membrane
architecture. We also suggest that P537R substitution might
unleash the interfacial bent structure and allow the adoption of
a more linear state, which would be unable to promote the
bilayer destabilization required for fusion development. High
resolution NMR studies are under way with the aim of ob-
taining further support for these hypotheses.
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